Since April 2020, the ACT-Accelerator partnership, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. With significant advances in research and development by academia, private sector and government initiatives, the ACT-Accelerator is on the cusp of securing a way to end the acute phase of the pandemic by deploying the tests, treatments and vaccines the world needs.
The Q4 Update charts progress achieved by ACT- Accelerator partners between 1 October and 31 December 2021 as they responded collectively to the global...
A four-page summary of the Framework can be found here. The ACT-A Facilitation Council Financial and Resource Mobilization Working Group developed...
The Vaccine Manufacturing Working Group (VMWG) was established by the Access to COVID-19 Tools Accelerators (ACT-Accelerator) Facilitation Council in May...
The ACT-Accelerator Commitment Tracker provides transparent reporting on funding commitments made against ACT-Accelerator Pillar budgets. Urgent action...
9 March 2022: The Q3 Update was amended to ensure that values for diagnostics, treatments and PPE procured, delivered, and funds awarded to countries are...
Note: Report updated on 15 Sept 2021 with removal of reference to the average price of antigen RDTs on page 3, removal of reference to price reductions...
This 2020-2021 Impact Report looks back at the challenges and progress of the ACT-Accelerator over the last year. It highlights the accelerated actions...
This document sets out WHO’s unique role and funding requirements to deliver on its role and work under the Access to COVID-19 Tools (ACT)-Accelerator,...
The Facilitation Council provides high-level political leadership and enabling advice on global advocacy and resource mobilization to facilitate the work of the COVID-19 Tools Accelerator (ACT-A), its global collaborative framework, and its partnerships to ensure the realization of the ACT-A vision: the rapid development, scale-up and equitable distribution of COVID-19 vaccines, therapeutics and diagnostics, underpinned by the strengthening of health systems.
Formally launched on 10 September 2020, the Council is currently co-chaired by Norway and South Africa.